Education
About Us
Working with TipRanks
Follow Us
Alligator Bioscience AB (SE:ATORX)
:ATORX
RESEARCH TOOLSreports
ATORX Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr3.69 - kr225.00
Previous CloseN/A
Volume998.30M
Average Volume (3M)535.01K
Market Cap
kr211.54M
Enterprise Valuekr1.06B
Total Cash (Recent Filing)kr28.85M
Total Debt (Recent Filing)kr41.86M
Price to Earnings (P/E)―
Beta1.40
Next Earnings
Jul 10, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1108.38
Shares Outstanding34,803,898
10 Day Avg. Volume754,157
30 Day Avg. Volume535,006
Financial Highlights & Ratios
PEG Ratio-0.15
Price to Book (P/B)4.81
Price to Sales (P/S)0.00
P/FCF Ratio-6.87
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Alligator Bioscience AB News
PremiumCompany Announcements
Alligator Bioscience to Present Promising Mitazalimab Data at ESMO GI 2025
PremiumCompany Announcements
Alligator Bioscience Expands Share Capital to Bolster Operations
PremiumCompany Announcements
Alligator Bioscience Receives EMA Endorsement for Phase 3 Mitazalimab Trial
PremiumCompany Announcements
Alligator Bioscience Receives FDA Endorsement for Phase 3 Mitazalimab Dose
PremiumCompany Announcements
Alligator Bioscience Unveils Promising OPTIMIZE-1 Trial Data at ASCO 2025
PremiumCompany Announcements
Alligator Bioscience Secures Capital Through Directed Share Issue
PremiumCompany Announcements
Alligator Bioscience’s HLX22 Receives European Orphan Drug Designation
ATORX FAQ
What was Alligator Bioscience AB’s price range in the past 12 months?
Alligator Bioscience AB lowest stock price was kr3.69 and its highest was kr225.00 in the past 12 months.
What is Alligator Bioscience AB’s market cap?
Alligator Bioscience AB’s market cap is kr211.54M.
When is Alligator Bioscience AB’s upcoming earnings report date?
Alligator Bioscience AB’s upcoming earnings report date is Jul 10, 2025 which is today.
How were Alligator Bioscience AB’s earnings last quarter?
Alligator Bioscience AB released its earnings results on Apr 24, 2025. The company reported -kr1108.38 earnings per share for the quarter, missing the consensus estimate of N/A by -kr1108.38.
Is Alligator Bioscience AB overvalued?
According to Wall Street analysts Alligator Bioscience AB’s price is currently Overvalued.
Does Alligator Bioscience AB pay dividends?
Alligator Bioscience AB does not currently pay dividends.
What is Alligator Bioscience AB’s EPS estimate?
Alligator Bioscience AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Alligator Bioscience AB have?
Alligator Bioscience AB has 34,803,898 shares outstanding.
What happened to Alligator Bioscience AB’s price movement after its last earnings report?
Alligator Bioscience AB reported an EPS of -kr1108.38 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.467%.
Which hedge fund is a major shareholder of Alligator Bioscience AB?
Currently, no hedge funds are holding shares in SE:ATORX
Company Description
Alligator Bioscience AB
Alligator Bioscience AB (ATORX) is a biotechnology company specializing in the development of innovative antibody-based therapies for the treatment of cancer. The company focuses on developing next-generation immuno-oncology treatments that harness the body's immune system to combat cancer. Its core products include a pipeline of drug candidates designed to target specific immune pathways and enhance the body's ability to fight tumors.
Technical Analysis
Active Biotech AB
―
Biosergen AB
―
Elicera Therapeutics AB
―
ExpreS2ion Biotech Holding AB
―
ExpreS2ion Biotech Holding AB
―
Xintela AB
―